Costs of Illness Due to Cholera, Costs of Immunization and Cost-Effectiveness of an Oral Cholera Mass Vaccination Campaign in Zanzibar

PLoS Neglected Tropical Diseases

Volumn 6, Issue 10, 2012, Pages

  Schaetti, Christian ^a,b   Weiss, Mitchell G ^a,b   Ali, Said M ^c   Chaignat, Claire Lise ^d   Khatib, Ahmed M ^c   Reyburn, Rita ^e   Duintjer Tebbens, Radboud J ^f   Hutubessy, Raymond ^d  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Ministry of Health Zanzibar   (Tanzania)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e International Vaccine Institute   (South Korea)

^f Kid Risk Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; RINGER LACTATE SOLUTION;

ADULT; CHOLERA; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEATH; DIARRHEA; DRUG COST; HEALTH CARE PERSONNEL; HUMAN; INTERVIEW; MASS IMMUNIZATION; OUTCOME ASSESSMENT; QUALITY ADJUSTED LIFE YEAR; REVIEW; SENSITIVITY ANALYSIS; TANZANIA;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHILD; CHOLERA; CHOLERA VACCINES; COHORT STUDIES; COST OF ILLNESS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MASS VACCINATION; TANZANIA; YOUNG ADULT;

EID: 84869044786     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001844     Document Type: Review

References (51)

1. World Health Organization (2010) Cholera, 2009. Wkly Epidemiol Rec 85: 293-308.
2. Ali M, Lopez AL, You YA, Kim YE, Sah B, et al. (2012) The global burden of cholera. Bull World Health Organ 90: 209-218A.
3. World Health Organization (2011) Cholera fact sheet No 107, August 2011. Available: http://www.who.int/mediacentre/factsheets/fs107/en/index.html. Accessed 2012 Mar 13.
4. Kirigia JM, Sambo LG, Yokouide A, Soumbey-Alley E, Muthuri LK, et al. (2009) Economic burden of cholera in the WHO African region. BMC Int Health Hum Rights 9: 8.
5. Sack DA, Sack RB, Nair GB, Siddique AK, (2004) Cholera. Lancet 363: 223-233.
6. Nelson EJ, Nelson DS, Salam MA, Sack DA, (2010) Antibiotics for both moderate and severe cholera. N Engl J Med 364: 5-7.
7. World Health Organization (2010) Cholera vaccines: WHO position paper. Wkly Epidemiol Rec 85: 117-128.
8. Islam Z, Maskery B, Nyamete A, Horowitz MS, Yunus M, et al. (2008) Private demand for cholera vaccines in rural Matlab, Bangladesh. Health Policy 85: 184-195.
9. Kim D, Canh DG, Poulos C, Thoa LTK, Cook J, et al. (2008) Private demand for cholera vaccines in Hue,Vietnam. Value Health 11: 119-128.
10. Lucas MES, Jeuland M, Deen J, Lazaro N, MacMahon M, et al. (2007) Private demand for cholera vaccines in Beira, Mozambique. Vaccine 25: 2599-2609.
11. Whittington D, Sur D, Cook J, Chatterjee S, Maskery B, et al. (2009) Rethinking cholera and typhoid vaccination policies for the poor: private demand in Kolkata, India. World Dev 37: 399-409.
12. Thiem VD, Hossain MM, Nguyen DS, Nguyen TH, Rao MR, et al. (2003) Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam. J Health Popul Nutr 21: 304-308.
13. Poulos C, Riewpaiboon A, Stewart JF, Clemens J, Guh S, et al. (2012) Costs of illness due to endemic cholera. Epidemiol Infect 140: 500-509.
14. Cavailler P, Lucas M, Perroud V, McChesney M, Ampuero S, et al. (2006) Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Vaccine 24: 4890-4895.
15. Jeuland M, Cook J, Poulos C, Clemens J, Whittington D, et al. (2009) Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. Value Health 12: 899-908.
16. Jeuland M, Lucas M, Clemens J, Whittington D, (2009) A cost-benefit analysis of cholera vaccination programs in Beira, Mozambique. World Bank Econ Rev 23: 235-267.
17. Revolutionary Government of Zanzibar (2006) 2004/05 Household budget survey. Zanzibar: Office of Chief Government Statistician.
18. United Republic of Tanzania (2004) Tanzania 2002 population and housing census. Dar es Salaam: National Bureau of Statistics.
19. Revolutionary Government of Zanzibar (2009) Health information bulletin 2008. Zanzibar: Ministry of Health and Social Welfare of Zanzibar.
20. World Health Organization, Global Task Force on Cholera Control (2006) Cholera country profile: Zanzibar (Tanzania). Available: http://www.who.int/entity/cholera/countries/Zanzibar%20(Tanzania)%20country%20profile.pdf. Accessed 2011 Aug 12.
21. Reyburn R, Deen JL, Grais RF, Bhattacharya SK, Sur D, et al. (2011) The case for reactive mass oral cholera vaccinations. PLoS Negl Trop Dis 5: e952.
22. Shin S, Desai SN, Sah BK, Clemens JD, (2011) Oral vaccines against cholera. Clin Infect Dis 52: 1343-1349.
23. Clemens JD, Sack DA, Harris JR, Chakraborty J, Khan MR, et al. (1986) Field trial of oral cholera vaccines in Bangladesh. Lancet 2: 124-127.
24. Clemens JD, Sack DA, Harris JR, van Loon F, Chakraborty J, et al. (1990) Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335: 270-273.
25. Lucas ME, Deen JL, von Seidlein L, Wang XY, Ampuero J, et al. (2005) Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 352: 757-767.
26. Schaetti C, Khatib AM, Ali SM, Hutubessy R, Chaignat CL, et al. (2010) Social and cultural features of cholera and shigellosis in peri-urban and rural communities of Zanzibar. BMC Infect Dis 10: 339.
27. World Health Organization (2005) Guidelines for estimating the economic burden of diarrhoeal disease, with focus on assessing the costs of rotavirus diarrhoea. Geneva: WHO.
28. Ali M, Deen JL, Khatib A, Enwere G, von Seidlein L, et al. (2010) Paperless registration during survey enumerations and large oral cholera mass vaccination in Zanzibar, the United Republic of Tanzania. Bull World Health Organ 88: 556-559.
29. Sack DA, (2003) When should cholera vaccine be used in cholera-endemic areas? J Health Popul Nutr 21: 299-303.
30. Longini IM Jr, Nizam A, Ali M, Yunus M, Shenvi N, et al. (2007) Controlling endemic cholera with oral vaccines. PLoS Med 4: e336.
31. Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, et al. (2012) Direct and indirect effectiveness of an oral cholera vaccine in Zanzibar, East Africa: findings from a large mass vaccination campaign followed by an observational cohort study. Lancet Infect Dis in press.
32. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL (2005) Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press. 379 p.
33. World Health Organization (2008) Global burden of disease 2004 update: disability weights for diseases and conditions. Available: http://www.who.int/healthinfo/global_burden_disease/GBD2004_DisabilityWeights.pdf. Accessed 2011 Aug 11.
34. World Health Organization (2011) Life tables for WHO member states. Available: http://www.who.int/healthinfo/statistics/mortality_life_tables/en/. Accessed 2011 Aug 9.
35. World Health Organization (2001) Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health. Geneva: WHO.
36. DeRoeck D, Clemens JD, Nyamete A, Mahoney RT, (2005) Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 23: 2762-2774.
37. World Health Organization, Ad-hoc cholera vaccine working group (2009) Background paper on the integration of oral cholera vaccines into global cholera control programmes presented to the WHO SAGE. Available: http://www.who.int/entity/immunization/sage/1_Background_Paper_Cholera_Vaccines_FINALdraft_13_oct_v2.pdf. Accessed 2010 Dec 14.
38. World Health Organization (2008) WHO guide for standardization of economic evaluations of immunization programmes. Geneva: WHO.
39. Deen JL, von SL, Sur D, Agtini M, Lucas ME, et al. (2008) The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis 2: e173.
40. World Bank (2011) GDP per capita (current US$) 2009. Available: http://data.worldbank.org/indicator/NY.GDP.PCAP.CD. Accessed 2011 Aug 18.
41. Duintjer Tebbens RJ, Thompson KM, Hunink MG, Mazzuchi TA, Lewandowski D, et al. (2008) Uncertainty and sensitivity analyses of a dynamic economic evaluation model for vaccination programs. Med Decis Making 28: 182-200.
42. Sur D, Kanungo S, Sah B, Manna B, Ali M, et al. (2011) Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis 5: e1289.
43. Naficy AB, Trach DD, Ke NT, Chuc NT, Sorkin A, et al. (2001) Cost of immunization with a locally produced, oral cholera vaccine in Viet Nam. Vaccine 19: 3720-3725.
44. Legros D, Paquet C, Perea W, Marty I, Mugisha NK, et al. (1999) Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ 77: 837-842.
45. Chaignat CL, Monti V, Soepardi J, Petersen G, Sorensen E, et al. (2008) Cholera in disasters: do vaccines prompt new hopes? Expert Rev Vaccines 7: 431-435.
46. World Health Organization, Global Task Force on Cholera Control (2006) Use of the two-dose oral cholera vaccine in the context of a major natural disaster. Report of a mass vaccination campaign in Aceh Province, Indonesia, 2005. Geneva: WHO.
47. Van Damme W, Van Lerberghe W, (2004) Strengthening health services to control epidemics: empirical evidence from Guinea on its cost-effectiveness. Trop Med Int Health 9: 281-291.
48. Naficy A, Rao MR, Paquet C, Antona D, Sorkin A, et al. (1998) Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis. JAMA 279: 521-525.
49. Murray J, McFarland DA, Waldman RJ, (1998) Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera. Bull World Health Organ 76: 343-352.
50. Keusch GT, Fontaine O, Bhargava A, Boschi-Pinto C, Bhutta ZA, et al. (2006) Diarrheal diseases. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M et al., editors. Disease control priorities in developing countries. New York: Oxford University Press. pp. 371-388.
51. Schaetti C, Ali SM, Chaignat CL, Khatib AM, Hutubessy R, et al. (2012) Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar. PLoS One 7: e41527.